MicroRNAs as regulators of cardiac dysfunction in sepsis: pathogenesis and diagnostic potential

Zhen Liu1,2, Feiyang Li1,2, Ningcen Li1,2

  • 1Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Abstract

Insights

MicroRNAs (miRNAs) are key regulators in sepsis-induced cardiac dysfunction (SIMD), a severe complication of sepsis. Further research is needed to overcome challenges and translate miRNA potential into clinical diagnosis and treatment for SIMD.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Sepsis Pathophysiology

Background:

  • Sepsis is a life-threatening condition with uncontrolled immune responses leading to organ dysfunction.
  • Sepsis-induced cardiac dysfunction (SIMD) is a severe complication that significantly increases mortality.
  • MicroRNAs (miRNAs) are emerging as critical regulators in the pathogenesis of SIMD.

Purpose of the Study:

  • To review and analyze the current understanding of miRNA roles in sepsis-induced cardiac dysfunction.
  • To identify key pathological processes in SIMD regulated by miRNAs.
  • To highlight challenges and future directions for miRNA-based research and clinical application in SIMD.

Main Methods:

  • A comprehensive literature search was conducted in PubMed, Science Direct, and Embase up to September 2024.
  • Search terms included "miRNA" or "microRNA", "Cardiac" or "Heart", and "Sepsis" or "Septic".
  • 106 relevant research articles were included after rigorous screening and exclusion criteria were applied.

Main Results:

  • The pathogenesis of SIMD is complex, involving mitochondrial dysfunction, oxidative stress, cardiomyocyte apoptosis/pyroptosis, calcium homeostasis dysregulation, and hemodynamic changes.
  • miRNAs play diverse regulatory roles in these pathological processes within SIMD.
  • miRNAs show potential as diagnostic biomarkers for SIMD.

Conclusions:

  • miRNAs are significantly involved in the pathogenesis of SIMD.
  • Existing research faces challenges including small sample sizes, inconsistent measurement techniques, and unclear miRNA-target gene relationships.
  • Overcoming challenges in miRNA stability, delivery, off-target effects, and safety is crucial for clinical translation in SIMD diagnosis and treatment.